LOS ANGELES--(BUSINESS WIRE)--ImClone Systems Incorporated (NASDAQ: IMCL - News), a leader in the development and commercialization of novel cancer therapeutics, today announced that the 1000th patient has been enrolled in the independent national registry of patients with head and neck cancer known as LORHAN (Longitudinal Oncology Registry of Head And Neck carcinoma). The announcement was made in conjunction with the Company’s sponsorship of and participation in the American Society for Therapeutic Radiation and Oncology (ASTRO) 49th Annual Meeting, which is being held this week in Los Angeles. Radiation therapy is a core treatment option for patients with head and neck cancer.
